List of bibliographic references
Number of relevant bibliographic references: 5.
List of associated KwdEn.i
Nombre de documents | Descripteur |
2 | Adult |
2 | Aged |
2 | Antibodies, Monoclonal (therapeutic use) |
2 | Antineoplastic Agents (therapeutic use) |
2 | Antineoplastic Combined Chemotherapy Protocols (therapeutic use) |
2 | Female |
2 | Humans |
2 | Male |
2 | Melanoma (drug therapy) |
2 | Middle Aged |
1 | Adolescent |
1 | Aged, 80 and over |
1 | Antibodies, Monoclonal (administration & dosage) |
1 | Antibodies, Monoclonal, Humanized (administration & dosage) |
1 | Antibodies, Monoclonal, Humanized (adverse effects) |
1 | Antibodies, Monoclonal, Humanized (therapeutic use) |
1 | Antineoplastic Agents (administration & dosage) |
1 | Antineoplastic Agents (adverse effects) |
1 | Antineoplastic Combined Chemotherapy Protocols (adverse effects) |
1 | Disease Progression |
1 | Disease-Free Survival |
1 | Double-Blind Method |
1 | Drug Resistance, Neoplasm |
1 | Health Status |
1 | Intention to Treat Analysis |
1 | Kaplan-Meier Estimate |
1 | Melanoma (immunology) |
1 | Melanoma (mortality) |
1 | Melanoma (pathology) |
1 | Quality of Life |
1 | Skin Neoplasms (drug therapy) |
1 | Skin Neoplasms (immunology) |
1 | Skin Neoplasms (mortality) |
1 | Skin Neoplasms (pathology) |
1 | Time Factors |
1 | Treatment Outcome |
1 | Young Adult |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "F Stephen Hodi"
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i \
-Sk "F Stephen Hodi" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Allemagne
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= F Stephen Hodi
}}
| This area was generated with Dilib version V0.6.33. Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 | |